Literature DB >> 31149174

COMPARISON OF PLASMA PHENYLALANINE DETERMINATION BY DENSITOMETRY OF THIN-LAYER CHROMATOGRAMS AND BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY IN RELATION WITH THE SCREENING OF PHENYLKETONURIA.

C V Mihali1, M C Petrescu1, I Mândruţiu2, D Bechet2, T V Nistor3, V Turcuş1, A Ardelean1, Gh Benga1,2,4,5,6,7.   

Abstract

OBJECTIVE: To compare two chromatographic methodologies for determination of plasma phenylalanine (Phe) and their usefulness for diagnosing hyperphenylalaninemia (HPA) and phenylketonuria (PKU).
METHODS: The plasma amino acids were isolated and concentrated from blood collected from infants with HPA detected by newborn screening. The plasma Phe was determined in parallel by HPLC and by image-densitometry of 2D-TLC plates.
RESULTS: Typical examples of 2D-TLC plates and HPLC chromatograms from infants with HPA and PKU are presented and evaluated. The Phe spot was visible on 2D - TLC plates at Phe concentrations higher than 300 µmol/L. The standard calibration curve traced after image-densitometry of the Phe spot presented high dispersion of values at each concentration of Phe, high SD values, the equation of the curve having a low R-squared value (0.862). In contrast, the standard calibration curve obtained by HPLC shows linearity on the range of concentrations from 100 - 16,000 µmol/L, extremely small SD values, the equation of the curve has a very high R-squared value (0.999).
CONCLUSIONS: The HPLC methodology is appropriate to confirm HPA detected by newborn or selective screening of PKU. The 2D - TLC methodology is adequate to detect patients with severe PKU.

Entities:  

Keywords:  densitometry; high performance liquid chromatography (HPLC); hyperphenylalaninemia; phenylalanine; phenylketonuria; screening; thin layer chromatography (TLC)

Year:  2017        PMID: 31149174      PMCID: PMC6516440          DOI: 10.4183/aeb.2017.203

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  15 in total

1.  A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS.

Authors:  R GUTHRIE; A SUSI
Journal:  Pediatrics       Date:  1963-09       Impact factor: 7.124

2.  Influence of phenylalanine intake on phenylketonuria.

Authors:  H BICKEL; J GERRARD; E M HICKMANS
Journal:  Lancet       Date:  1953-10-17       Impact factor: 79.321

Review 3.  Phenylketonuria.

Authors:  Nenad Blau; Francjan J van Spronsen; Harvey L Levy
Journal:  Lancet       Date:  2010-10-23       Impact factor: 79.321

4.  Comparison of tandem mass spectrometry and amino acid analyzer for phenylalanine and tyrosine monitoring--implications for clinical management of patients with hyperphenylalaninemia.

Authors:  Urh Groselj; Simona Murko; Mojca Zerjav Tansek; Jernej Kovac; Alenka Trampus Bakija; Barbka Repic Lampret; Tadej Battelino
Journal:  Clin Biochem       Date:  2014-09-28       Impact factor: 3.281

5.  Newborn screening in southeastern Europe.

Authors:  Urh Groselj; Mojca Zerjav Tansek; Andraz Smon; Natalija Angelkova; Dana Anton; Ivo Baric; Maja Djordjevic; Lindita Grimci; Maria Ivanova; Adil Kadam; Vjosa Mulliqi Kotori; Hajrija Maksic; Oana Marginean; Otilia Margineanu; Olivera Milijanovic; Florentina Moldovanu; Mariana Muresan; Simona Murko; Michaela Nanu; Barbka Repic Lampret; Mira Samardzic; Vladimir Sarnavka; Aleksei Savov; Maja Stojiljkovic; Biljana Suzic; Radka Tincheva; Husref Tahirovic; Alma Toromanovic; Natalia Usurelu; Tadej Battelino
Journal:  Mol Genet Metab       Date:  2014-08-01       Impact factor: 4.797

Review 6.  Neurometabolic diseases in the newborn.

Authors:  James J Filiano
Journal:  Clin Perinatol       Date:  2006-06       Impact factor: 3.430

7.  Morning preprandial plasma ghrelin and catecholamine concentrations in patients with phenylketonuria and normal controls: evidence for catecholamine-mediated ghrelin regulation.

Authors:  Kleopatra H Schulpis; Ioannis Papassotiriou; Maria Vounatsou; George A Karikas; Stylianos Tsakiris; George P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

8.  Fifty years of phenylketonuria newborn screening - A great success for many, but what about the rest?

Authors:  Urh Groselj; Mojca Zerjav Tansek; Tadej Battelino
Journal:  Mol Genet Metab       Date:  2014-07-25       Impact factor: 4.797

9.  Phenylalanine hydroxylase deficiency: diagnosis and management guideline.

Authors:  Jerry Vockley; Hans C Andersson; Kevin M Antshel; Nancy E Braverman; Barbara K Burton; Dianne M Frazier; John Mitchell; Wendy E Smith; Barry H Thompson; Susan A Berry
Journal:  Genet Med       Date:  2013-10-10       Impact factor: 8.822

10.  Blood phenylalanine monitoring for dietary compliance among patients with phenylketonuria: comparison of methods.

Authors:  Cria O Gregory; Chunli Yu; Rani H Singh
Journal:  Genet Med       Date:  2007-11       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.